ArticleVox sanguinis2026
Pre-donation deferral rates and causes among whole blood and apheresis platelet donors in China: A multi-centre retrospective study (2016-2024).
Article in Vox sanguinis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesPre-donation deferral can negatively affect donor retention and blood supply sustainability. Comprehensive analysis of national deferral rates and reasons can inform evidence-based adjustments to donor eligibility criteria and improve the specificity of pre-donation screening. MATERIALS AND
methodsData on deferral rates and the top three deferral causes were collected from 47 blood establishments (BEs) (23 provincial-level, 24 prefectural-level) across China between 2016 and 2024. Deferral reasons were classified into 16 standardized categories. Chi-square and Spearman correlation analyses were performed to examine differences between groups and associations with potential influencing factors.
resultsA total of 42.6 million whole blood (WB) and 5.9 million apheresis platelet (AP) donation attempts were analysed. Overall deferral rates were 11.4% for WB and 14.7% for AP donations, with provincial-level BEs exhibiting higher rates than prefectural-level BEs, for both donation types. The most frequently reported deferral reasons were elevated alanine aminotransferase (ALT) levels, low haemoglobin (Hb), lipaemia and abnormal blood pressure. Deferral rates were positively associated with the proportion of first-time donors and, for WB donors, with the detection rate of hepatitis B surface antigen (HBsAg).
conclusionPre-donation deferral remains relatively high in China, with elevated ALT, low Hb, lipaemia and abnormal blood pressure identified as the most frequent causes. These findings highlight the need for evidence-based revisions of eligibility criteria, targeted donor education and strategies to promote repeat donation. Standardizing pre-donation screening practices across BEs may reduce unnecessary deferrals, enhance donor retention and support a more efficient and sustainable blood supply.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.